Literature DB >> 11704231

Meigs' syndrome with an elevated CA 125 from benign Brenner tumors.

B M Buttin1, D E Cohn, T J Herzog.   

Abstract

BACKGROUND: Meigs' syndrome refers to solid, benign ovarian tumors, ascites, hydrothorax, and resolution of these signs after surgery. Meigs' syndrome with an elevated CA 125 secondary to benign Brenner tumors is exceedingly rare. CASE: A postmenopausal woman presented with a large pelvic mass, ascites, and a right pleural effusion. Serum CA 125 was 759 IU/mL. Ascitic fluid, pleural fluid, and fine needle aspiration of the mass were without evidence of malignancy. Exploratory laparotomy with total abdominal hysterectomy and bilateral salpingo-oophorectomy revealed benign Brenner tumors. Immunohistochemical staining for CA 125 showed immunoreactivity in the omentum only. Postoperatively, her signs and symptoms resolved completely and did not recur.
CONCLUSION: Cytologic or histologic confirmation of malignancy is imperative in patients with a pelvic mass, ascites, hydrothorax, and elevated CA 125 before initiating chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704231     DOI: 10.1016/s0029-7844(01)01562-9

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Ovarian thecoma with massive pleural effusion in postmenopausal women: A case report.

Authors:  Yang Ting; L I Yang; Zhao Juan; Wei Xing; Yang Xiao Feng
Journal:  Mol Clin Oncol       Date:  2016-04-07

2.  Struma Ovarii Associated with Ascites and Elevated CA125: Two Case Reports and Review of the Literature.

Authors:  Shaoyu Wang; Xinqin He; Huijuan Yang; Lihong Chen
Journal:  Int J Womens Health       Date:  2022-09-07

3.  Meigs' Syndrome with Elevated Serum CA125: Case Report and Review of the Literature.

Authors:  Mongkol Benjapibal; Suthi Sangkarat; Somsak Laiwejpithaya; Boonlert Viriyapak; Pattama Chaopotong; Atthapon Jaishuen
Journal:  Case Rep Oncol       Date:  2009-04-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.